CSS
INSY

Cubist Systematic Strategies’s Insys Therapeutics, Inc. INSY Stock Holding History

Cubist Systematic Strategies’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-38,392
Closed -$134K – 2521
2018
Q4 		$134K Buy
+38,392
New +$267K 0.01% 1680
2017
Q2 		– Sell
-677
Closed -$7K – 1988
2017
Q1 		$7K Sell
677
-15,679
-96% -$167K ﹤0.01% 1575
2016
Q4 		$150K Buy
16,356
+15,507
+1,827% +$175K 0.01% 1369
2016
Q3 		$10K Buy
+849
New +$12.9K ﹤0.01% 1640
2015
Q1 		– Sell
-1,200
Closed -$25K – 2181
2014
Q4 		$25K Buy
+1,200
New +$23.7K ﹤0.01% 1815

Other funds holding INSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Cubist Systematic Strategies's INSY Position: Q1 2019 in Review

Cubist Systematic Strategies sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 38,392 shares — an estimated $134K sold.

Cubist Systematic Strategies first reported a position in INSY in Q4 2014 and held it in 5 quarters. The position peaked at $150K in Q4 2016. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

  • Cubist Systematic Strategies reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Cubist Systematic Strategies sold 38,392 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $134K.
  • Cubist Systematic Strategies first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 5 quarters.
  • Cubist Systematic Strategies's Insys Therapeutics, Inc. position peaked at $150K in Q4 2016.
  • 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on Cubist Systematic Strategies's 13F filing for Q1 2019, filed 15 May 2019.